Commentary: Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma.
作者信息
Andereggen Lukas, Christ Emanuel
机构信息
Department of Neurosurgery, Kantonsspital Aarau, Aarau, Switzerland.
Faculty of Medicine, University of Bern, Bern, Switzerland.
出版信息
Front Endocrinol (Lausanne). 2024 Feb 27;15:1371424. doi: 10.3389/fendo.2024.1371424. eCollection 2024.
Abstract
摘要
相似文献
1
Commentary: Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma.
Front Endocrinol (Lausanne). 2024 Feb 27;15:1371424. doi: 10.3389/fendo.2024.1371424. eCollection 2024.
2
Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma.
Front Endocrinol (Lausanne). 2023 Nov 6;14:1241145. doi: 10.3389/fendo.2023.1241145. eCollection 2023.
3
Childhood craniopharyngioma - changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007.
Klin Padiatr. 2014 May;226(3):161-8. doi: 10.1055/s-0034-1368785. Epub 2014 May 12.
4
Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma.
Front Endocrinol (Lausanne). 2023 Jun 2;14:1180591. doi: 10.3389/fendo.2023.1180591. eCollection 2023.
5
Childhood-onset craniopharyngioma: latest insights into pathology, diagnostics, treatment, and follow-up.
Expert Rev Neurother. 2018 Oct;18(10):793-806. doi: 10.1080/14737175.2018.1528874. Epub 2018 Oct 4.
6
Risk-adapted, long-term management in childhood-onset craniopharyngioma.
Pituitary. 2017 Apr;20(2):267-281. doi: 10.1007/s11102-016-0751-0.
7
Magnetic resonance imaging-graded hypothalamic compression in surgically treated adult craniopharyngiomas determining postoperative obesity.
Neurosurg Focus. 2010 Apr;28(4):E3. doi: 10.3171/2010.1.FOCUS09303.
8
Oxytocin in survivors of childhood-onset craniopharyngioma.
Endocrine. 2016 Nov;54(2):524-531. doi: 10.1007/s12020-016-1084-5. Epub 2016 Sep 1.
9
Craniopharyngioma: Surgical Outcome as Related to the Degree of Hypothalamic Involvement.
World Neurosurg. 2017 Aug;104:1006-1010. doi: 10.1016/j.wneu.2017.02.115.
10
In Reply to "Craniopharyngioma: Surgical Outcome as Related to the Degree of Hypothalamic Involvement".
World Neurosurg. 2017 Aug;104:1011-1013. doi: 10.1016/j.wneu.2017.03.040.
本文引用的文献
1
Surgical outcomes and follow-up results of 53 pediatric craniopharyngioma cases: a single-center study.
J Neurosurg Pediatr. 2023 Dec 29;33(3):223-235. doi: 10.3171/2023.10.PEDS23293. Print 2024 Mar 1.
2
Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma.
Front Endocrinol (Lausanne). 2023 Nov 6;14:1241145. doi: 10.3389/fendo.2023.1241145. eCollection 2023.
3
Vision-related quality of life in patients with childhood-onset craniopharyngioma.
Sci Rep. 2023 Nov 10;13(1):19599. doi: 10.1038/s41598-023-46532-y.
4
Treatment of hypothalamic obesity in people with hypothalamic injury: new drugs are on the horizon.
Front Endocrinol (Lausanne). 2023 Sep 13;14:1256514. doi: 10.3389/fendo.2023.1256514. eCollection 2023.
5
Does subtotal resection ameliorate hypothalamic morbidity in pediatric craniopharyngioma? A 30-year retrospective cohort study.
J Neurosurg Pediatr. 2023 Aug 11;32(5):569-575. doi: 10.3171/2023.5.PEDS22568. Print 2023 Nov 1.
6
The importance of long-term follow-up in clinical trials.
Lancet Glob Health. 2023 Jul;11(7):e995-e996. doi: 10.1016/S2214-109X(23)00244-9.
7
Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma.
Front Endocrinol (Lausanne). 2023 Jun 2;14:1180591. doi: 10.3389/fendo.2023.1180591. eCollection 2023.
8
Comparison of neurocognitive and quality-of-life outcomes in pediatric craniopharyngioma patients treated with partial resection and radiotherapy versus gross-total resection only.
J Neurosurg Pediatr. 2023 Feb 17;31(5):453-462. doi: 10.3171/2022.12.PEDS22367. Print 2023 May 1.
9
Treatment of Acquired Hypothalamic Obesity: Now and the Future.
Front Endocrinol (Lausanne). 2022 Apr 6;13:846880. doi: 10.3389/fendo.2022.846880. eCollection 2022.
10
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement.
Eur J Endocrinol. 2022 Apr 21;186(6):P35-P52. doi: 10.1530/EJE-21-1186.
Zotero 插件